PARIS: Anti-malarial drugs chloroquine and hydroxychloroquine should only be used to treat COVID-19 in clinical trials or in case of "national emergency", the European Medicine Agency warned on Wednesday.
Around the world, countries are expanding access to the two compounds, which are used to treat malaria and are known to have anti-viral properties. The medicines have shown early promise against the COVID-19 illness in early studies in France and China.
"It is very important that patients and healthcare professionals only use chloroquine and hydroxychloroquine for their authorised uses or as part of clinical trials or national emergency-use programmes for the treatment of COVID-19," it said.
Both drugs have a number of potentially serious side effects, especially when taken in high doses or administered in tandem with other medications. "They must not be used without a prescription and without supervision by a doctor; prescriptions should not be given outside their authorised uses except in the setting of a clinical trial or nationally agreed protocols," the EMA said in a statement.
After Joe Biden’s 2020 election win, Warsaw did not officially recognise him as US president for several weeks
“If you tell this story anywhere in Europe, no one is going to believe you,” Magyar said
Many Panamanians streaming out of voting stations cited graft as one of their main concerns
The previous longest baguette of 132.62 meters was baked in the Italian city of Como in June 2019
The village is in northwest of onetime Ukrainian stronghold of Avdiivka which Russia captured in February
Lauga reached out to police early on April 28 and an investigation is underway, she said in an instagram post